History Taking

Hematuria

Hematuria is the presence of red blood cells in the urine, which may be visible (gross) or detectable only microscopically, indicating potential urinary tract pathology.

History Taking: Hematuria (血尿)


1. Presenting Complaint Framework

The structured approach to hematuria essentially asks four key questions sequentially. Get these right and you've framed the entire case.

2. Detailed Symptom Analysis (SOCRATES + Associations)

Once the four framework questions are answered, systematically flesh out the HPI:

6. Social History (社交史)

High Yield Summary

Definition: Gross hematuria = visible blood in urine; Microscopic = ≥ 3 RBC/HPF. Always confirm dipstick with microscopy.

Most important cause to exclude: Malignancy — painless gross hematuria in any adult > 35 years is urothelial cancer until proven otherwise.

Blood clots = ALWAYS non-glomerular (urokinase/tPA in glomeruli prevent clotting).

Glomerular vs Non-glomerular: Dysmorphic RBCs/RBC casts = glomerular → nephrology. Isomorphic RBCs = urological → cystoscopy + imaging.

Key risk factors for urological malignancy (must ask): Smoking (pack-years), age > 35, male sex, occupational chemical exposure (rubber, dye, petroleum), aristolochic acid (TCM), cyclophosphamide, prior pelvic radiation, chronic UTI.

Anticoagulants/antiplatelets do NOT explain hematuria (except warfarin OD) — always investigate.

Timing in stream: Initial = anterior urethra; Terminal = bladder neck/posterior urethra; Throughout = bladder/upper tract (but unreliable).

Causes by site (from the lecture slide):

  • Kidney: stone, AML, infection, trauma, polycystic kidney, medical causes, RCC
  • Ureter: stone, TCC
  • Bladder: infection, stone, irradiation cystitis, bladder cancer
  • Prostate: BPH, prostate cancer
  • Urethra: infection, urethral cancer

Risk stratification (AUA): Low risk → repeat UA in 6 months; Intermediate → cystoscopy + renal USS; High risk → cystoscopy + CT urogram.

High Yield Summary

Framework: Always start with Glomerular vs Non-Glomerular → then sub-classify by anatomical site.

Glomerular DDx (dysmorphic RBCs, RBC casts, proteinuria): IgA nephropathy (most common), thin BM disease, Alport syndrome, post-infectious GN, lupus nephritis, ANCA vasculitis, anti-GBM disease.

Non-glomerular DDx by site (isomorphic RBCs ± clots):

  • Kidney: RCC, AML, polycystic kidney, pyelonephritis, TB, renal infarction, papillary necrosis, trauma
  • Ureter: Stone, TCC (field cancerization)
  • Bladder: CA bladder (most common urinary malignancy), cystitis, stone, irradiation cystitis, haemorrhagic cystitis
  • Prostate: BPH, CA prostate, prostatitis
  • Urethra: Urethritis, trauma, urethral CA

Most common cause: UTI (~60%). Most worrying: Malignancy — painless gross hematuria in > 35 y/o = urothelial cancer until proven otherwise.

Red flags in "recurrent UTI": Persistent hematuria after treatment → must exclude malignancy with cystoscopy. Sterile pyuria → TB, ketamine cystitis. Recurrent urease-producing organisms → underlying stone.

Bleeding disorders/anticoagulants: NOT a satisfactory explanation — 81% have underlying urinary pathology. Always investigate.

Pseudohematuria: Haemoglobinuria, myoglobinuria (dipstick +ve, no RBCs), drugs/food (dipstick -ve, no RBCs).

High Yield Summary

Step 1 — Confirm true hematuria: Centrifuge → red sediment = true hematuria; red supernatant + dipstick +ve = haemoglobinuria/myoglobinuria; red supernatant + dipstick -ve = drug/food/porphyria.

Step 2 — Characterise: Urine microscopy → dysmorphic RBCs / RBC casts = glomerular → nephrology. Isomorphic RBCs ± clots = non-glomerular → urology.

Step 3 — Exclude UTI first (MSU C/ST). If hematuria persists after treating UTI → full workup.

Step 4 — Risk stratify (AUA 2020 for microscopic hematuria): Low → repeat UA in 6 months; Intermediate → cystoscopy + renal USG; High → cystoscopy + CT urogram.

Gross hematuria: Always gets full workup — cystoscopy + CTU ± urine cytology × 3.

CTU has 3 phases: Non-contrast (stones), nephrographic (renal masses), excretory (urothelial lesions).

Cystoscopy: Only modality that can detect papillary TCC as small as 1 mm and CIS. Non-invasive tests CANNOT replace cystoscopy for bladder CA diagnosis.

Urine cytology: High specificity ( > 98%) but low sensitivity (~50% overall); best for high-grade TCC and CIS; send fresh, 2nd void, 3 consecutive days.

Glomerular workup: Complement (C3/C4) is the branch point → ↓complement = IC-mediated GN (lupus, PSGN, MPGN); normal complement = non-IC GN (IgAN, ANCA vasculitis, anti-GBM). Renal biopsy for definitive diagnosis.

Renal biopsy indications: Proteinuria > 1 g/day, rising creatinine, active sediment with persistent hematuria.

Refer to nephrology when: Urological cause excluded, ↓GFR, significant proteinuria, young + HTN + isolated hematuria, visible hematuria with URTI.

High Yield Summary

Emergency hematuria: ABC → large-bore 3-way catheter → manual clot evacuation → CBI with NS → urgent rigid cystoscopy if fails → angioembolisation for upper tract bleeding.

Management principle: Hematuria is a symptom — find and treat the cause. Medical causes → nephrologist; Urological causes → urologist.

Glomerular pathway: ACEI/ARB for ALL GN (↓intraglomerular pressure → ↓proteinuria → renoprotective). Specific immunosuppression guided by renal biopsy histology. Lupus nephritis treatment is determined by ISN/RPS class, not just clinical presentation.

Bladder cancer: TURBT for NMIBC ± intravesical BCG; radical cystectomy ± neoadjuvant chemo for MIBC. Cystoscopy/TURBT can NEVER be replaced by non-invasive tests.

RCC: Partial nephrectomy for T1 (preserves renal function); radical nephrectomy for T2+; immunotherapy (ipilimumab + nivolumab) for metastatic poor/intermediate risk.

Urolithiasis: NSAIDs first-line for pain (also ↓ureteral spasm); MET with tamsulosin for 5–10 mm distal ureteric stones; urgent decompression (PCN or JJ stent) if sepsis/AKI; surgical choice depends on stone site and size (ESWL for small renal/upper ureteric, URS for ureteric, PCNL for large renal).

BPH: Surgical indications = complications (refractory AROU, recurrent UTI, recurrent hematuria, renal insufficiency, bladder stones). TURP gold standard. Monopolar uses glycine (risk of TUR syndrome); bipolar uses NS (safer).

3-way catheter: For hematuria with clot formation → allows CBI. Suprapubic catheter if urethral catheterisation contraindicated/failed.

Negative workup: Monitor RFT + urinalysis yearly; re-investigate if new symptoms or risk factors emerge.

High Yield Summary

Complications of hematuria itself:

  • Clot retention = most important acute complication → AROU → needs 3-way catheter + CBI ± cystoscopic clot evacuation
  • Anaemia from chronic blood loss → check CBC; iron deficiency suggests ongoing occult bleeding
  • Clot colic from upper tract bleeding → vermiform clots obstruct ureter → mimics renal colic

Complications of underlying causes:

  • Bladder cancer: hydronephrosis (distal ureteric obstruction), fistulae (vesicocolic → pneumaturia; vesicovaginal → incontinence), metastasis (liver, lung, bone), recurrence (field cancerisation → lifelong cystoscopy surveillance)
  • Urolithiasis: urosepsis (obstructed + infected = emergency), pyonephrosis, hydronephrosis, obstructive AKI
  • GN: progressive CKD, nephrotic complications (VTE, infection), RPGN
  • BPH: AROU, chronic retention, UTI, bladder stones, obstructive uropathy, post-obstructive diuresis

Iatrogenic complications:

  • TURP: TUR syndrome (hyponatraemia from glycine absorption — monopolar only), retrograde ejaculation (65–75%), bleeding
  • TURBT: bladder perforation, obturator nerve reflex
  • Nephrectomy: bleeding, CKD (radical > partial)
  • Radical cystectomy: high morbidity (30–60%), urinary diversion complications, ED
  • Radical prostatectomy: ED (30–80%), urinary incontinence (5–20%)
  • ESWL: steinstrasse, perinephric haematoma
  • Catheterisation: CAUTI, haemorrhage ex-vacuo, post-obstructive diuresis, transient hypotension

The cost of delay: Single episode of painless gross hematuria in > 35 y/o + risk factors → MUST investigate urgently. Bladder cancer bleeds intermittently — resolution of hematuria does NOT mean resolution of disease.

On this page

No Headings